Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) fell 8.3% during trading on Tuesday . The company traded as low as $1.00 and last traded at $1.00. 2,410 shares were traded during mid-day trading, a decline of 73% from the average session volume of 9,053 shares. The stock had previously closed at $1.09.
Peak Pharmaceuticals Stock Down 13.1%
The business has a fifty day moving average of $1.05 and a 200 day moving average of $1.71.
Peak Pharmaceuticals Company Profile
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
Featured Articles
- Five stocks we like better than Peak Pharmaceuticals
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
- Palo Alto Networks Accelerates Growth 31% on AI Demand
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
